|
Volumn 2, Issue 2, 2001, Pages 185-198
|
Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFLATOXIN B1;
ALPHA NAPHTHOFLAVONE;
BENZO[A]PYRENE;
CARBAMAZEPINE;
CYTOCHROME P450 3A4;
DEXTROMETHORPHAN;
DIAZEPAM;
DICLOFENAC;
FLAVONE;
ISOPROTEIN;
LIGAND;
LIVER ENZYME;
LOSARTAN;
MIDAZOLAM;
NEW DRUG;
PHENANTHRENE;
PROGESTERONE;
QUINIDINE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;
TANGERETIN;
WARFARIN;
WATER;
ZOXAZOLAMINE;
ALLOSTERISM;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BINDING SITE;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG STRUCTURE;
DRUG TRANSFORMATION;
ENZYME ACTIVATION;
ENZYME ACTIVE SITE;
ENZYME ACTIVITY;
ENZYME BINDING;
ENZYME CONFORMATION;
ENZYME INDUCTION;
ENZYME INHIBITION;
ENZYME MECHANISM;
ENZYME METABOLISM;
ENZYME SUBSTRATE;
HUMAN;
HUMAN CELL;
HYDROXYLATION;
IN VITRO STUDY;
IN VIVO STUDY;
INHIBITION KINETICS;
LIGAND BINDING;
LIVER CELL;
LIVER CLEARANCE;
LIVER TOXICITY;
MONKEY;
NONHUMAN;
RAT;
RISK ASSESSMENT;
TRANSPORT KINETICS;
ANIMALS;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
HUMANS;
LIVER;
MIXED FUNCTION OXYGENASES;
PHARMACEUTICAL PREPARATIONS;
|
EID: 0034976635
PISSN: 13892002
EISSN: None
Source Type: Journal
DOI: 10.2174/1389200013338658 Document Type: Article |
Times cited : (147)
|
References (58)
|